Status:
COMPLETED
Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation
Lead Sponsor:
Pfizer
Conditions:
Ejaculation
Eligibility:
MALE
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Assessment of efficacy and safety UK-390,957.
Eligibility Criteria
Inclusion
- Premature ejaculation as defined by DSM-IV
Exclusion
- History of erectile dysfunction
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
460 Patients enrolled
Trial Details
Trial ID
NCT00219583
Start Date
August 1 2004
End Date
June 1 2005
Last Update
November 7 2012
Active Locations (49)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Bondi Junction, New South Wales, Australia
2
Pfizer Investigational Site
St Leonards, New South Wales, Australia
3
Pfizer Investigational Site
Spring Hill, Queensland, Australia
4
Pfizer Investigational Site
Adelaide, South Australia, Australia